Characteristics of chief investigators and principal investigators in Australian and New Zealand radiation oncology clinical trials.

Hanh NguyenRebecca MontgomeryPurnima Sundaresan

Published in: Journal of medical imaging and radiation oncology (2023)

This study highlights the gaps in diversity amongst CIs and PIs in TROG clinical trials. Further unpacking and understanding of issues related to CI and PI diversity are important to inform initiatives to improve researcher, leadership and patient diversity in future TROG clinical trials.

Keyphrases

clinical trial
phase ii
open label
double blind
case report
phase iii
study protocol
randomized controlled trial
quality improvement
drug induced